Renal Medulla is More Sensitive to Cisplatin than Cortex Revealed by Untargeted Mass Spectrometry-Based Metabolomics in Rats
Renal Medulla is More Sensitive to Cisplatin than Cortex Revealed by Untargeted Mass Spectrometry-Based Metabolomics in Rats
复制标题
基于非靶向质谱的大鼠代谢组学显示,肾髓质对顺铂比皮质更敏感
DOI:
10.1038/srep44804
复制
发表时间:
2017-03
影响因子:
4.6
通讯作者:
Xu Feng Guo
中科院分区:
文献类型:
--
作者:
Zhang Pei;Chen Jia Qing;Huang Wan Qiu;Li Wei;Huang Yin;Zhang Zun Jian;Xu Feng Guo
Nephrotoxicity has long been the most severe and life-threatening side-effect of cisplatin, whose anticancer effect is therefore restricted. Previous pathological studies have shown that both renal cortex and medulla could be injured by cisplatin. Our TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling) assay results further uncovered that medulla subjected more severe injury than cortex. In order to depict the underlying metabolic mechanism of spatial difference in response to cisplatin, in the present study, mass spectrometry-based untargeted metabolomics approach was applied to profile renal cortex and medulla metabolites of rat after receiving a single dose of cisplatin (2.5, 5 or 10 mg/kg). Eventually, 53 and 55 differential metabolites in cortex and medulla were screened out, respectively. Random forest, orthogonal partial least squares-discriminant analysis and metabolic cumulative fold change analysis revealed that metabolic changes in medulla were more obviously dose-dependent than those in cortex, which confirmed the conclusion that medulla was more sensitive to cisplatin exposure. Furthermore, 29 intermediates were recognized as the most contributive metabolites for the sensitivity difference. Metabolic pathways interrupted by cisplatin mainly included amino acid, energy, lipid, pyrimidine, purine, and creatine metabolism. Our findings provide new insight into the mechanism study of cisplatin-induced nephrotoxicity.
登录
查看更多内容
DOI:
10.1097/00000441-196107000-00060
发表时间:
1961-07
期刊:
--
影响因子:
--
作者:
A. C. Guyton;J. Hall
通讯作者:
A. C. Guyton;J. Hall
影响因子:
4.3
作者:
Huang, Yin;Tian, Yuan;Zhang, Zunjian
通讯作者:
Zhang, Zunjian
影响因子:
19.6
作者:
Tsuruya, K;Ninomiya, T;Iida, M
通讯作者:
Iida, M
DOI:
10.1097/00000421-199004000-00009
发表时间:
1990-04
期刊:
American Journal of Clinical Oncology
影响因子:
--
作者:
Milton Rabinowits;L. Souhami;R. Gil;C. Andrade;H. Paiva
通讯作者:
Milton Rabinowits;L. Souhami;R. Gil;C. Andrade;H. Paiva
DOI:
--
发表时间:
1980-06
期刊:
The Journal of pharmacology and experimental therapeutics
影响因子:
--
作者:
D. Dobyan;J. Levi;C. Jacobs;J. Kosek;M. Weiner
通讯作者:
D. Dobyan;J. Levi;C. Jacobs;J. Kosek;M. Weiner